Jeffrey Bray - Sabra Health Ex Ops

All Insiders . Germany . 
Stock . Sabra Health Care . Stakeholders . Insider . Jeffrey Bray
SBC Stock  EUR 14.99  0.43  2.79%   

Insider

Jeffrey Bray is Ex Ops of Sabra Health Care
Phone772 287 4000
Webhttps://www.seacoastbanking.com

Sabra Health Management Efficiency

The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0241) %, meaning that it generated substantial loss on money invested by shareholders. Sabra Health's management efficiency ratios could be used to measure how well Sabra Health manages its routine affairs as well as how well it operates its assets and liabilities.
Sabra Health Care has accumulated 2.31 B in total debt with debt to equity ratio (D/E) of 106.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sabra Health Care has a current ratio of 5.79, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Sabra Health until it has trouble settling it off, either with new capital or with free cash flow. So, Sabra Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sabra Health Care sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sabra to invest in growth at high rates of return. When we think about Sabra Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Matthew BreitmanTake Two Interactive Software
N/A
Karl SlatoffTake Two Interactive Software
53
Lainie GoldsteinTake Two Interactive Software
55
JD EsqTake Two Interactive Software
66
Sam HouserTake Two Interactive Software
N/A
Vivien ChanUnited Overseas Insurance
N/A
Nicole ShevinsTake Two Interactive Software
N/A
Siew ChiaLimUnited Overseas Insurance
N/A
BBA BBAUnited Overseas Insurance
69
Michael CondreyTake Two Interactive Software
N/A
Kwee SimUnited Overseas Insurance
N/A
Linda ZabriskieTake Two Interactive Software
N/A
Daniel EmersonTake Two Interactive Software
51
Kian LokUnited Overseas Insurance
N/A
David IsmailerTake Two Interactive Software
N/A
As of March 31, 2019, Sabras investment portfolio included 437 real estate properties held for investment 304 Skilled NursingTransitional Care facilities, 88 Senior Housing communities , 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements and 22 Specialty Hospitals and Other facilities, 30 assets held for sale, one investment in a direct financing lease, 20 investments in loans receivable one mortgage loan, two construction loans and 17 other loans, nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing Managed communities. As of March 31, 2019, Sabras real estate properties held for investment included 43,884 bedsunits and its unconsolidated joint venture included 7,652 bedsunits, spread across the United States and Canada Sabra Health Care (SBC) is traded on Frankfurt Exchange in Germany and employs 42 people.

Management Performance

Return On Equity-0.0241
Return On Asset0.0155

Sabra Health Care Leadership Team

Elected by the shareholders, the Sabra Health's board of directors comprises two types of representatives: Sabra Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sabra. The board's role is to monitor Sabra Health's management team and ensure that shareholders' interests are well served. Sabra Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sabra Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Peter Nyland, Ex Management
Talya NevoHacohen, Chief VP
Michael Costa, CFO VP
Jeffrey Bray, Ex Ops
Darrin Smith, Ex Investments
Lukas CFA, VP Fin
Michael Sonego, Ex Exec
Joseph Forlenza, Ex Officer
Daniel Chappell, Chief VP
Charles Cross, Ex Pres
Juliette Kleffel, Ex Officer
Jeffery Lee, Ex Officer
Jennifer Reissman, Ex Officer
Tracey Dexter, Ex CFO
Eliza Gozar, VP Investments
Charles Shaffer, Pres Chairman
Harold Andrews, Consultant
Richard Matros, Pres Chairman

Sabra Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sabra Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.0241
Return On Asset0.0155
Profit Margin(0.15) %
Operating Margin0.27 %
Current Valuation5.1 B
Shares Outstanding231.16 M
Shares Owned By Insiders1.35 %
Shares Owned By Institutions90.40 %
Price To Earning25.24 X
Price To Book0.90 X

Currently Active Assets on Macroaxis

CRMSalesforce
CCitigroup
GMGeneral Motors
WDWalker Dunlop
MSFTMicrosoft

Other Information on Investing in Sabra Stock

Sabra Health financial ratios help investors to determine whether Sabra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabra with respect to the benefits of owning Sabra Health security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY